Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults

Alimentary Pharmacology and Therapeutics

Volumn 42, Issue 10, 2015, Pages 1149-1157

  Szajewska, H ^a   Kolodziej M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

ADULT; ANTIBIOTIC INDUCED DIARRHEA; BACTERIAL STRAIN; CHILD; COCHRANE LIBRARY; DIARRHEA; DRUG INDUCED DISEASE; EMBASE; ERADICATION THERAPY; EVIDENCE BASED PRACTICE; HELICOBACTER PYLORI; HUMAN; INFORMATION RETRIEVAL; LACTOBACILLUS RHAMNOSUS; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; ANTI-BACTERIAL AGENTS; CHILD; DIARRHEA; HUMANS; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84943660582     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13404     Document Type: Review

References (34)

1. Bartlett JG,. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-9.
2. Alam S, Mushtaq M,. Antibiotic associated diarrhea in children. Indian Pediatr 2009; 46: 491-6.
3. McFarland LV,. Systematic review and meta-analysis of Saccha-romyces boulardii in adult patients. World J Gastroenterol 2010; 14: 2202-22.
4. Wiström J, Norrby SR, Myhre EB, et al,. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001; 47: 43-50.
5. Coté GA, Buchman AL,. Antibiotic-associated diarrhoea. Expert Opin Drug Saf 2006; 5: 361-72.
6. Hurley BW, Nguyen CC,. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 2002; 28: 2177-84.
7. Hill C, Guarner F, Reid G, et al,. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11: 506-14.
8. Surawicz CM,. Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract Res Clin Gastroenterol 2003; 17: 775-83.
9. Hempel S, Newberry SJ, Maher AR, et al,. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307: 1959-69.
10. Hawrelak JA, Whitten DL, Myers SP,. Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review. Digestion 2005; 72: 51-6.
11. Yan F, Polk DB,. Lactobacillus rhamnosus GG: an updated strategy to use microbial products to promote health. Funct Food Rev 2012; 4: 77-84.
12. Lu R, Fasano S, Madayiputhiya N, Morin NP, Nataro J, Fasano A,. Isolation, identification, and characterization of small bioactive peptides from Lactobacillus GG conditional media that exert both anti-Gram-negative and Gram-positive bactericidal activity. J Pediatr Gastroenterol Nutr 2009; 49: 23-30.
13. Szajewska H, Kolodziej M,. Systematic review and meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2015; 42: 793-801.
14. Szajewska H, Horvath A, Kołodziej M,. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2015; 41: 1237-45.
15. Higgins JPT, Green S, (eds.) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org.
16. Moher D, Liberati A, Tetzlaff J, Altman DG,; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
17. Schüunemann H, Brozek J, Guyatt G, Oxman A, (eds). GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations [Updated October 2013]. The GRADE Working Group, 2013. Available at: http://www.guidelinedevelopment.org/handbook.
18. Guyatt GH, Oxman AD, Kunz R, et al,. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64: 395-400.
19. Egger M, Smith GD, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-34.
20. Szajewska H, Albrecht P, Topczewska-Cabanek A,. Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. J Pediatr Gastroenterol Nutr 2009; 48: 431-6.
21. Vanderhoof JA, Whitney DB, Antonson DL,. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135: 564-8.
22. Thomas MR, Litin SC, Osmon DR,. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc 2001; 76: 883-9.
23. Cremonini F, Di Caro S, Covino M,. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-9.
24. Arvola T, Laiho K, Torkkeli S,. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104: e64.
25. Armuzzi A, Cremonini F, Bartolozzi F,. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15: 163-9.
26. Armuzzi A, Cremonini F, Ojetti V,. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63: 1-7.
27. Padilla Ruiz M, Fernández Aguiar ME, Arce Nuñez M, Polo Amorín R,. Lactobacillus rhamnosus GG supplementation to reduce side-effects of anti-Helicobacter pylori treatment. Rev Gastroenterol Peru 2013; 33: 121-30. Spanish.
28. King SN, Chung AM, Vidal R,. Randomized, double blind, placebo controlled trial to assess the efficacy of Lactobacillus GG in the prevention of antibiotic-associated diarrhea in the Pediatric Internsive Care Unit (PICU). Pharmacotherapy 2010; 30: 457-8.
29. Vaisanen ML, Leskinen M, Siitonen A,. Occurrence of diarrhea in children receiving oral antibiotics with or without probiotic supplementation with Lactobacillus GG. Microb Ecol Health Dis 1998; 10: 158-204 (Abstract).
30. Goldenberg JZ, Ma SS, Saxton JD, et al,. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2013; 5: CD006095.
31. Mc Farland LV,. Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections. Benef Microbes 2015; 6: 189-94.
32. McFarland LV,. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101: 812-22.
33. Pattani R, Palda VA, Hwang SW, Shah PS,. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med 2013; 7: 56-67.
34. Xie C, Li J, Wang K, Li Q, Chen D,. Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review. Travel Med Infect Dis 2015; 13: 128-34.